iPoster : Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen for Hormone Receptor-Positive Breast Cancer in Women Younger Than 35 (ASPAIT): A Multicenter Randomized Clinical Trial

Download PDF

Add Notes

Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen for Hormone Receptor-Positive Breast Cancer in Women Younger Than 35 (ASPAIT): A Multicenter Randomized Clinical Trial